Purinergic (P2Y) Receptors

5 个项目

每页

设置降序顺序
  1. Prasugrel (Effient)

    Catalog No. A10748
    Quick View
    platelet inhibitor
    Prasugrel (Effient)是一种新型的血小板抑制剂,用于减少急性冠脉综合征(PCI)患者的血栓性心血管事件(包括支架血栓形成)。 了解更多
  2. Clopidogrel

    Catalog No. A21206
    Quick View
    platelet inhibitor
    Clopidogrel is a well-known and orally active platelet inhibitor that targets P2Y12 receptor. Clopidogrel is used to inhibit blood clots in coronary artery disease, peripheral vascular disease, and cerebrovascular disease. 了解更多
  3. Cangrelor Tetrasodium

    Catalog No. A17919
    Quick View
    P2Y12 receptors inhibitor
    Cangrelor Tetrasodium is a high-affinity, reversible inhibitor of P2Y12 receptors that causes almost complete inhibition of ADP-induced platelet aggregate. It is a modified ATP derivative stable to enzymatic degradation. Unlike clopidogrel (Plavix), which is a prodrug, cangrelor is an active drug not requiring metabolic conversion. 了解更多
  4. Vicagrel

    Catalog No. A18586
    Quick View
    P2Y12 platelet inhibitor
    Vicagrel, an acetate derivative of Clopidogrel, is a P2Y12 platelet inhibitor potentially for the treatment of thrombosis. 了解更多
  5. Clopidogrel thiolactone

    Catalog No. A20862
    Quick View
    P2Y12 receptor inhibitor
    Clopidogrel thiolactone is a P2Y12 receptor inhibitor, is a potent antiplatelet agent. 了解更多

5 个项目

每页

设置降序顺序
Rewards